MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Pioneers: Research_Academia, Government Labs, Non-Profits, Industry
*1. Academia_Cutting Edge Research & Discovery
Pioneers (Academic R&D) Rankings, Ratings & Reviews
Pioneer: Regional Rankings & Data
*Bioscience Regional Clusters & HotSpots
*Industry: Northern California & Silicon Valley
Aduro Biotech Inc. (ADRO)
Organization & Developments: Aduro
Parents
Aduro Biotech Inc. (ADRO)
Children
2010: The Company's product is referred to as the Targeted Nano-Therapeutics (TNT) System (2010)
2015: Why Aduro Biotech Is Crashing Today
2017: Aduro Biotech: Buy, Sell Or Hold? - Aduro Biotech (NASDAQ:ADRO)
2018: J&J shrugs off deals with Aduro that were worth up to $1.2B. Setback forces shift to Novartis alliance now – Endpoints News
2020: Aduro's staffers feel the sting, again, after Novartis walks away
2020: Once a high flyer, a staggering Aduro is auctioning off most of the pipeline as CEO Stephen Isaacs hands off the shell to new owners – Endpoints News
626 Bancroft Way, 3C
Developing non-invasive targeted therapeutics for the treatment of cancers.
DEVELOPS IMMUNOTHERAPIES TO SLOW THE GROWTH AND SPREAD OF OR ELIMINATE TUMOR CELLS.
TBS is developing this anticancer therapy to treat late-stage cancers such as breast, head and neck, lung, colon, ovarian, pancr
The Company has leveraged its experience with magnetic nano-materials and magnetic field energy to make antibodies tumoricidal a
Jumps
*Key People: Aduro Biotech
Finance & Acquisitions: Aduro